LB

Lini Basil

Active Director Director DIN 08964482
DIN 08964482 First appointment Nov 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Lini Basil

Data last updated:

Lini Basil is a Director at Bylin Medtech Private Limited (since 2020). The company operates in Healthcare. Bylin Medtech Private Limited reported revenue of ₹21.7 Lakh (FY 2025).

DIN 08964482
Primary Designation Director
Industry Healthcare
First Appointment 18 Nov 2020
Oldest Company Age 5 yrs
Largest company Bylin Medtech Private Limited · ₹21.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bylin Medtech Private Limited U33119KL2020PTC065811
Director18 Nov 20202020₹21.7 Lakh (FY 2025)Active

Board colleagues of Lini Basil

NameDINCompanyDesignation
Alexander Kongalathu Alexander08964493Bylin Medtech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bylin Medtech Private Limited
Premium access

Shareholding and investment profile for Lini Basil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lini Basil

Lini Basil currently holds 1 directorship: Bylin Medtech Private Limited (Director, since 18 Nov 2020, revenue ₹21.7 Lakh (FY 2025)).

Lini Basil was first appointed on 18 Nov 2020 as Director at Bylin Medtech Private Limited.

The current boards of Lini Basil's companies include Alexander Kongalathu Alexander (Bylin Medtech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available